申请人:KYOWA HAKKO KOGYO CO., LTD.
公开号:EP0130555A2
公开(公告)日:1985-01-09
A dibenz[b,e]oxepin derivative having an anti-allergic activity is represented by the following general formula:
wherein R1 represents a cyano group, a 5-tetrazolyl group, a carbamoyl group or -CO2R3 [wherein R3 represents a hydrogen atom, an alkyl group having 1 to 5 carbon atoms or a 1-(ethoxycarbonyloxy)ethyl group], and R2 represents a 4-alkylpiperazino group (wherein the alkyl group has 1 to 5 carbon atoms), a 3-quinuclidinylamino group or -X-(CH2)n-NR4R5 (wherein X represents -NH-, -S- or -0-, R4 and R5 are same or different and each represents an alkyl group having 1 to 5 carbon atoms and n represents 2 or 3): and the pharmaceutically acceptable acid addition salts or metal salts thereof.
具有抗过敏活性的二苯并[b,e]氧杂卓衍生物由以下通式表示:
其中 R1 代表氰基、5-四唑基、氨基甲酰基或 -CO2R3 [其中 R3 代表氢原子、具有 1 至 5 个碳原子的烷基或 1-(乙氧基羰基氧基)乙基]、和 R2 代表 4-烷基哌嗪基团(其中烷基具有 1 至 5 个碳原子)、3-奎宁环氨基基团或 -X-(CH2)n-NR4R5(其中 X 代表-NH-、-S- 或-0-,R4 和 R5 相同或不同,且各自代表具有 1 至 5 个碳原子的烷基,n 代表 2 或 3):及其药学上可接受的酸加成盐或金属盐。